Köpenysejtes limfóma: vizsgálatok itt: Egyesült Királyság
10 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- Where
- Glasgow, Lincoln, London, Manchester, Oxford, Plymouth
- Életkor
- 18 év and over
- People
- 182 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06084936 - 1. fázisTaking peopleA Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Where
- Leeds, Oxford
- Életkor
- 18 év and over
- People
- 215 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07101328 · EU 2025-524180-20-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
- Where
- Birmingham, Bournemouth, Glasgow, Headington, London, Metropolitan Borough of Wirral, Plymouth
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06742996 · EU 2024-515593-27-00 - 1/2. fázisTaking peopleA Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
- Where
- Derriford, London, Oxford, Southampton
- Életkor
- 18 év and over
- People
- 408 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06564038 · EU 2024-515034-33-00 - 1/2. fázisTaking peopleA Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
- Where
- Birmingham, Leeds
- Életkor
- 18 év and over
- People
- 258 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06697184 · EU 2024-518829-15-00 - 1/2. fázisTaking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Edinburgh, Leeds, Newcastle upon Tyne, Newmarket, Norwich, Nottingham, Plymouth
- Életkor
- 18 év and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - 1. fázisTaking peopleDose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
- Where
- Leeds, Plymouth
- Életkor
- 18 év and over
- People
- 85 worldwide
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT06980116 · EU 2024-516869-36-00 - 1. fázisTaking peopleA Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Where
- Glasgow, Leeds, Liverpool, London, Manchester, Oxford, Plymouth, Southampton, Sutton
- Életkor
- 18 év and over
- People
- 572 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00 - 1/2. fázisTaking peopleA Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
- Where
- Birmingham, Cambridge, Leeds, London, Manchester, Sutton
- Életkor
- 16 év and over
- People
- 84
- Run by
- Cancer Research UK
See details and how to joinNCT06045910 - 2. fázisTaking peopleZanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
- Where
- Derby, Glasgow, Liverpool, London, Manchester, Norwich, Nottingham, Oxford, Plymouth, Southampton, Truro
- Életkor
- 18 év and over
- People
- 50
- Run by
- University College, London
See details and how to joinNCT05635162